Abstract
Objectives
Lipid mediators are bioactive lipids which help regulate inflammation. We aimed to develop an ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method to quantify 58 pro-inflammatory and pro-resolving lipid mediators in plasma, determine preliminary reference ranges for adolescents, and investigate how total parenteral nutrition (TPN) containing omega-3 polyunsaturated fatty acid (n-3 PUFA) or n-6 PUFA based lipid emulsions influence lipid mediator concentrations in plasma.
Methods
Lipid mediators were extracted from plasma using SPE and measured using UHPLC-MS/MS. EDTA plasma was collected from healthy adolescents between 13 and 17 years of age to determine preliminary reference ranges and from mice given intravenous TPN for seven days containing either an n-3 PUFA or n-6 PUFA based lipid emulsion.
Results
We successfully quantified 43 lipid mediators in human plasma with good precision and recovery including several leukotrienes, prostaglandins, resolvins, protectins, maresins, and lipoxins. We found that the addition of methanol to human plasma after blood separation reduces post blood draw increases in 12-hydroxyeicosatetraenoic acid (12-HETE), 12-hydroxyeicosapentaenoic acid (12-HEPE), 12S-hydroxyeicosatrienoic acid (12S-HETrE), 14-hydroxydocosahexaenoic acid (14-HDHA) and thromboxane B2 (TXB2). Compared to the n-6 PUFA based TPN, the n-3 PUFA based TPN increased specialized pro-resolving mediators such as maresin 1 (MaR1), MaR2, protectin D1 (PD1), PDX, and resolvin D5 (RvD5), and decreased inflammatory lipid mediators such as leukotriene B4 (LTB4) and prostaglandin D2 (PGD2).
Conclusions
Our method provides an accurate and sensitive quantification of 58 lipid mediators from plasma samples, which we used to establish a preliminary reference range for lipid mediators in plasma samples of adolescents; and to show that n-3 PUFA, compared to n-6 PUFA rich TPN, leads to a less inflammatory lipid mediator profile in mice.
Award Identifier / Grant number: 173088, 177225
-
Research funding: This study was supported by a project grant (#173088) and a Sinergia grant (#177225) of the Swiss National Science Foundation. The funding organization played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.
-
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
-
Competing interests: Authors state no conflict of interest.
-
Informed consent: Informed consent was obtained from all individuals included in this study.
-
Ethical approval: The research related to human use has complied with all the relevant national regulations, institutional policies, and in accordance with the tenets of the Helsinki Declaration, and has been approved by the authors’ Institutional Review Board or equivalent committee (Clinical trial registry number, NCT04158869). The research related to animals’ use has complied with all the relevant national regulations and institutional policies for the care and use of animals (University of Alberta Animal Policy and Welfare Committee, AUP00002007).
References
1. Serhan, CN. Pro-resolving lipid mediators are leads for resolution physiology. Nature 2014;510:92–101. https://doi.org/10.1038/nature13479.Search in Google Scholar PubMed PubMed Central
2. Levy, BD, Clish, CB, Schmidt, B, Gronert, K, Serhan, CN. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2001;2:612–9. https://doi.org/10.1038/89759.Search in Google Scholar PubMed
3. Serhan, CN, Petasis, NA. Resolvins and protectins in inflammation resolution. Chem Rev 2011;111:5922–43. https://doi.org/10.1021/cr100396c.Search in Google Scholar PubMed PubMed Central
4. Serhan, CN, Chiang, N, van Dyke, TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349–61. https://doi.org/10.1038/nri2294.Search in Google Scholar PubMed PubMed Central
5. Levy, BD, de Sanctis, GT, Devchand, PR, Kim, E, Ackerman, K, Schmidt, B, et al.. Lipoxins and aspirin-triggered lipoxins in airway responses. In: Yazici, Z, Folco, GC, Drazen, JM, Nigam, S, Shimizu, T, editors. Advances in prostaglandin, leukotriene and other bioactive lipid research: basic science and clinical applications. Boston, MA: Springer US; 2003:19–23 pp.10.1007/978-1-4419-9194-2_5Search in Google Scholar PubMed
6. Neuhofer, A, Zeyda, M, Mascher, D, Itariu, BK, Murano, I, Leitner, L, et al.. Impaired local production of proresolving lipid mediators in obesity and 17-HDHA as a potential treatment for obesity-associated inflammation. Diabetes 2013;62:1945–56. https://doi.org/10.2337/db12-0828.Search in Google Scholar PubMed PubMed Central
7. González-Périz, A, Horrillo, R, Ferré, N, Gronert, K, Dong, B, Morán-Salvador, E, et al.. Obesity-induced insulin resistance and hepatic steatosis are alleviated by omega-3 fatty acids: a role for resolvins and protectins. Faseb J 2009;23:1946–57. https://doi.org/10.1096/fj.08-125674.Search in Google Scholar PubMed PubMed Central
8. Gemperle, C, Schmid, M, Herova, M, Marti-Jaun, J, Wuest, SJA, Loretz, C, et al.. Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophages. PloS One 2012;7:e50195. https://doi.org/10.1371/journal.pone.0050195.Search in Google Scholar PubMed PubMed Central
9. Herová, M, Schmid, M, Gemperle, C, Hersberger, M. ChemR23, the receptor for chemerin and resolvin E1, is expressed and functional on M1 but not on M2 macrophages. J Immunol 2015;194:2330–7. https://doi.org/10.4049/jimmunol.1402166.Search in Google Scholar PubMed
10. Hersberger, M. Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins. Clin Chem Lab Med 2010;48:1063–73. https://doi.org/10.1515/CCLM.2010.212.Search in Google Scholar PubMed
11. Gabbs, M, Leng, S, Devassy, JG, Monirujjaman, M, Aukema, HM. Advances in our understanding of oxylipins derived from dietary PUFAs. Adv Nutr: Int Rev J 2015;6:513–40. https://doi.org/10.3945/an.114.007732.Search in Google Scholar PubMed PubMed Central
12. Mas, E, Croft, KD, Zahra, P, Barden, A, Mori, TA. Resolvins D1, D2, and other mediators of self-limited resolution of inflammation in human blood following n-3 fatty acid supplementation. Clin Chem 2012;58:1476–84. https://doi.org/10.1373/clinchem.2012.190199.Search in Google Scholar PubMed
13. Fischer, R, Konkel, A, Mehling, H, Blossey, K, Gapelyuk, A, Wessel, N, et al.. Dietary omega-3 fatty acids modulate the eicosanoid profile in man primarily via the CYP-epoxygenase pathway. J Lipid Res 2014;55:1150–64. https://doi.org/10.1194/jlr.m047357.Search in Google Scholar PubMed PubMed Central
14. Itariu, BK, Zeyda, M, Hochbrugger, EE, Neuhofer, A, Prager, G, Schindler, K, et al.. Long-chain n-3 PUFAs reduce adipose tissue and systemic inflammation in severely obese nondiabetic patients: a randomized control trial. Am J Clin Nutr 2012;96:1137–49. https://doi.org/10.3945/ajcn.112.037432.Search in Google Scholar PubMed
15. Schuchardt, JP, Ostermann, AI, Stork, L, Fritzsch, S, Kohrs, H, Greupner, T, et al.. Effect of DHA supplementation on oxylipin levels in plasma and immune cell stimulated blood. Prostaglandins Leukot Essent Fatty Acids 2017;121:76–87. https://doi.org/10.1016/j.plefa.2017.06.007.Search in Google Scholar PubMed
16. Grenon, SM, Owens, CD, Nosova, EV, Hughes-Fulford, M, Alley, HF, Chong, K, et al.. Short-term, high-dose fish oil supplementation increases the production of omega-3 fatty acid-derived mediators in patients with peripheral artery disease (the OMEGA-PAD I trial). Journal Am Heart Assoc 2015;4:e002034. https://doi.org/10.1161/JAHA.115.002034.Search in Google Scholar PubMed PubMed Central
17. Schaller, MS, Chen, M, Colas, RA, Sorrentino, TA, Lazar, AA, Grenon, SM, et al.. Treatment with a marine oil supplement alters lipid mediators and leukocyte phenotype in healthy patients and those with peripheral artery disease. Journal Am Heart Assoc 2020;9:e016113. https://doi.org/10.1161/JAHA.120.016113.Search in Google Scholar PubMed PubMed Central
18. Dyall, SC. Interplay between n-3 and n-6 long-chain polyunsaturated fatty acids and the endocannabinoid system in brain protection and repair. Lipids 2017;52:885–900. https://doi.org/10.1007/s11745-017-4292-8.Search in Google Scholar PubMed PubMed Central
19. Wood, JT, Williams, JS, Pandarinathan, L, Janero, DR, Lammi-keefe, CJ, Makriyannis, A. Dietary docosahexaenoic acid supplementation alters select physiological endocannabinoid-system metabolites in brain and plasma. J Lipid Res 2010;51:1416–23. https://doi.org/10.1194/jlr.m002436.Search in Google Scholar
20. Artmann, A, Petersen, G, Hellgren, LI, Boberg, J, Skonberg, C, Nellemann, C, et al.. Influence of dietary fatty acids on endocannabinoid and N-acylethanolamine levels in rat brain, liver and small intestine. Biochim Biophys Acta 2008;1781:200–12. https://doi.org/10.1016/j.bbalip.2008.01.006.Search in Google Scholar PubMed
21. Lou, P-H, Lucchinetti, E, Wawrzyniak, P, Morsy, Y, Wawrzyniak, M, Scharl, M, et al.. Choice of lipid emulsion determines inflammation of the gut-liver Axis, incretin profile, and insulin signaling in a murine model of total parenteral nutrition. Mol Nutr Food Res 2020 Jul 30. https://doi.org/10.1002/mnfr.202000412 [Epub ahead of print].Search in Google Scholar PubMed
22. Hajeyah, AA, Griffiths, WJ, Wang, Y, Finch, AJ, O’Donnell, VB. The biosynthesis of enzymatically oxidized lipids. Front Endocrinol 2020;11:591819. https://doi.org/10.3389/fendo.2020.591819.Search in Google Scholar PubMed PubMed Central
23. Wolfer, AM, Gaudin, M, Taylor-Robinson, SD, Holmes, E, Nicholson, JK. Development and validation of a high-throughput ultrahigh-performance liquid chromatography-mass spectrometry approach for screening of oxylipins and their precursors. Anal Chem 2015;87:11721–31. https://doi.org/10.1021/acs.analchem.5b02794.Search in Google Scholar PubMed
24. Yuan, ZX, Majchrzak-Hong, S, Keyes, GS, Iadarola, MJ, Mannes, AJ, Ramsden, CE. Lipidomic profiling of targeted oxylipins with ultra-performance liquid chromatography-tandem mass spectrometry. Anal Bioanal Chem 2018;410:6009–29. https://doi.org/10.1007/s00216-018-1222-4.Search in Google Scholar PubMed PubMed Central
25. Colas, RA, Shinohara, M, Dalli, J, Chiang, N, Serhan, CN. Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue. Am J Physiol Cell Physiol 2014;307:C39–54. https://doi.org/10.1152/ajpcell.00024.2014.Search in Google Scholar PubMed PubMed Central
26. Sorokin, AV, Norris, PC, English, JT, Dey, AK, Chaturvedi, A, Baumer, Y, et al.. Identification of proresolving and inflammatory lipid mediators in human psoriasis. J Clin Lipidol 2018;12:1047–60. https://doi.org/10.1016/j.jacl.2018.03.091.Search in Google Scholar PubMed PubMed Central
27. See, VHL, Mas, E, Prescott, SL, Beilin, LJ, Burrows, S, Barden, AE, et al.. Effects of prenatal n-3 fatty acid supplementation on offspring resolvins at birth and 12 years of age: a double-blind, randomised controlled clinical trial. Br J Nutr 2017;118:971–80. https://doi.org/10.1017/s0007114517002914.Search in Google Scholar
28. Calder, PC. Eicosapentaenoic and docosahexaenoic acid derived specialised pro-resolving mediators: concentrations in humans and the effects of age, sex, disease and increased omega-3 fatty acid intake. Biochimie 2020 Aug 26. https://doi.org/10.1016/j.biochi.2020.08.015 [Epub ahead of print].Search in Google Scholar PubMed
29. Ostermann, AI, West, AL, Schoenfeld, K, Browning, LM, Walker, CG, Jebb, SA, et al.. Plasma oxylipins respond in a linear dose-response manner with increased intake of EPA and DHA: results from a randomized controlled trial in healthy humans. Am J Clin Nutr 2019;109:1251–63. https://doi.org/10.1093/ajcn/nqz016.Search in Google Scholar PubMed
30. Jonasdottir, HS, Brouwers, H, Toes, REM, Ioan-Facsinay, A, Giera, M. Effects of anticoagulants and storage conditions on clinical oxylipid levels in human plasma. Biochim Biophys Acta Mol Cell Biol Lipids 2018;1863:1511–22. https://doi.org/10.1016/j.bbalip.2018.10.003.Search in Google Scholar PubMed
31. Röhrig, W, Achenbach, S, Deutsch, B, Pischetsrieder, M. Quantification of 24 circulating endocannabinoids, endocannabinoid-related compounds, and their phospholipid precursors in human plasma by UHPLC-MS/MS. J Lipid Res 2019;60:1475–88. https://doi.org/10.1194/jlr.d094680.Search in Google Scholar
32. Hahnefeld, L, Gurke, R, Thomas, D, Schreiber, Y, Schäfer, SMG, Trautmann, S, et al.. Implementation of lipidomics in clinical routine: can fluoride/citrate blood sampling tubes improve preanalytical stability? Talanta 2020;209:120593. https://doi.org/10.1016/j.talanta.2019.120593.Search in Google Scholar PubMed
33. Yoshimoto, T, Yoshitaka, T. Arachidonate 12-lipoxygenases. Prostag Other Lipid Mediat 2002;68-69:245–62. https://doi.org/10.1016/s0090-6980(02)00034-5.Search in Google Scholar PubMed
34. Freedman, CJ, Tran, A, Tourdot, BE, Kalyanaraman, C, Perry, S, Holinstat, M, et al.. Biosynthesis of the maresin intermediate 13S 14S-epoxy- DHA by human 15-lipoxygenase and 12-lipoxygenase and its regulation through negative allosteric modulators. Biochemistry 2020;59:1832–44. https://doi.org/10.1021/acs.biochem.0c00233.Search in Google Scholar PubMed PubMed Central
35. Porro, B, Songia, P, Squellerio, I, Tremoli, E, Cavalca, V. Analysis, physiological and clinical significance of 12-HETE: a neglected platelet-derived 12-lipoxygenase product. J Chromatogr B Analyt Technol Biomed Life Sci 2014;964:26–40. https://doi.org/10.1016/j.jchromb.2014.03.015.Search in Google Scholar PubMed
36. Serhan, CN, Sheppard, KA. Lipoxin formation during human neutrophil-platelet interactions. Evidence for the transformation of leukotriene A4 by platelet 12-lipoxygenase in vitro. J Clin Invest 1990;85:772–80. https://doi.org/10.1172/jci114503.Search in Google Scholar PubMed PubMed Central
37. Leiria, LO, Wang, C-H, Lynes, MD, Yang, K, Shamsi, F, Sato, M, et al.. 12-Lipoxygenase regulates cold adaptation and glucose metabolism by producing the omega-3 lipid 12-HEPE from Brown fat. Cell Metabol 2019;30:768–83.e7. https://doi.org/10.1016/j.cmet.2019.07.001.Search in Google Scholar PubMed PubMed Central
38. Yeung, J, Tourdot, BE, Adili, R, Green, AR, Freedman, CJ, Fernandez-Perez, P, et al.. 12(S)-HETrE, a 12-lipoxygenase oxylipin of dihomo-γ-linolenic acid, inhibits thrombosis via gαs signaling in platelets. Arterioscler Thromb Vasc Biol 2016;36:2068–77. https://doi.org/10.1161/atvbaha.116.308050.Search in Google Scholar
39. Norris, PC, Libreros, S, Chiang, N, Serhan, CN. A cluster of immunoresolvents links coagulation to innate host defense in human blood. Sci Signal 2017;10. https://doi.org/10.1126/scisignal.aan1471.Search in Google Scholar PubMed PubMed Central
40. Dalli, J, Colas, RA, Quintana, C, Barragan-Bradford, D, Hurwitz, S, Levy, BD, et al.. Human sepsis eicosanoid and proresolving lipid mediator temporal profiles: correlations with survival and clinical outcomes. Crit Care Med 2017;45:58–68. https://doi.org/10.1097/ccm.0000000000002014.Search in Google Scholar
41. Pradelli, L, Mayer, K, Klek, S, Omar Alsaleh, AJ, Clark, RAC, Rosenthal, MD, et al.. ω-3 fatty-acid enriched parenteral nutrition in hospitalized patients: systematic review with meta-analysis and trial sequential analysis. JPEN - J Parenter Enter Nutr 2020;44:44–57. https://doi.org/10.1002/jpen.1672.Search in Google Scholar PubMed PubMed Central
42. Pradelli, L, Klek, S, Mayer, K, Omar Alsaleh, AJ, Rosenthal, MD, Heller, AR, et al.. Omega-3 fatty acid-containing parenteral nutrition in ICU patients: systematic review with meta-analysis and cost-effectiveness analysis. Crit Care 2020;24:634. https://doi.org/10.1186/s13054-020-03356-w.Search in Google Scholar PubMed PubMed Central
43. Calder, PC. Intravenous lipid emulsions to deliver bioactive omega-3 fatty acids for improved patient outcomes. Mar Drugs 2019;17:274. https://doi.org/10.3390/md17050274.Search in Google Scholar PubMed PubMed Central
44. Kalish, BT, Le, HD, Fitzgerald, JM, Wang, S, Seamon, K, Gura, KM, et al.. Intravenous fish oil lipid emulsion promotes a shift toward anti-inflammatory proresolving lipid mediators. Am J Physiol Gastrointest Liver Physiol 2013;305:818–28. https://doi.org/10.1152/ajpgi.00106.2013.Search in Google Scholar PubMed PubMed Central
45. Körner, A, Schlegel, M, Theurer, J, Frohnmeyer, H, Adolph, M, Heijink, M, et al.. Resolution of inflammation and sepsis survival are improved by dietary Ω-3 fatty acids. Cell Death Differ 2018;25:421–31. https://doi.org/10.1038/cdd.2017.177.Search in Google Scholar PubMed PubMed Central
46. Basil, MC, Levy, BD. Specialized pro-resolving mediators: endogenous regulators of infection and inflammation. Nat Rev Immunol 2016;16:51–67. https://doi.org/10.1038/nri.2015.4.Search in Google Scholar PubMed PubMed Central
47. Chiang, N, Fredman, G, Bäckhed, F, Oh, SF, Vickery, T, Schmidt, BA, et al.. Infection regulates pro-resolving mediators that lower antibiotic requirements. Nature 2012;484:524–8. https://doi.org/10.1038/nature11042.Search in Google Scholar PubMed PubMed Central
48. Diaz, LA, Altman, NH, Khan, WN, Serhan, CN, Adkins, B. Specialized proresolving mediators rescue infant mice from lethal Citrobacter rodentium infection and promote immunity against reinfection. Infect Immun 2017;85. https://doi.org/10.1128/IAI.00464-17.Search in Google Scholar PubMed PubMed Central
49. Qiu, S, Li, P, Zhao, H, Li, X. Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4/NF-kB signaling pathway. Int Immunopharm 2020;78:106018. https://doi.org/10.1016/j.intimp.2019.106018.Search in Google Scholar PubMed
50. Qiao, N, Lin, Y, Wang, Z, Chen, J-Y, Ge, Y-Y, Yao, S-L, et al.. Maresin1 promotes M2 macrophage polarization through peroxisome proliferator-activated receptor-γ activation to expedite resolution of acute lung injury. J Surg Res 2020;256:584–94. https://doi.org/10.1016/j.jss.2020.06.062.Search in Google Scholar PubMed
51. Sobrino, A, Walker, ME, Colas, RA, Dalli, J. Protective activities of distinct omega-3 enriched oils are linked to their ability to upregulate specialized pro-resolving mediators. PloS One 2020;15:e0242543. https://doi.org/10.1371/journal.pone.0242543.Search in Google Scholar PubMed PubMed Central
52. Lv, C, Jin, Q. Maresin-1 inhibits oxidative stress and inflammation and promotes apoptosis in a mouse model of caerulein-induced acute pancreatitis. Med Sci Monit 2019;25:8181–9. https://doi.org/10.12659/msm.917380.Search in Google Scholar
53. Lucchinetti, E, Lou, P-H, Wawrzyniak, P, Wawrzyniak, M, Scharl, M, Holtzhauer, GA, et al.. Novel strategies to prevent total parenteral nutrition-induced gut and liver inflammation, and adverse metabolic outcomes. Mol Nutr Food Res 2020 May 2. https://doi.org/10.1002/mnfr.201901270 [Epub ahead of print].Search in Google Scholar PubMed
Supplementary Material
The online version of this article offers supplementary material (https://doi.org/10.1515/cclm-2021-0644).
© 2021 Walter de Gruyter GmbH, Berlin/Boston
